SCHEMBL2897379

SCHEMBL2897379

Cn1cccc(Oc2ccc(F)cc2)c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.45
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
SCN4A P35499 1/20 0.41
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
MAP2K1 Q02750 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
BRD4 O60885 5/20 0.39
HTR1A P08908 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
MAPK14 Q16539 1/20 0.38
LMNA P02545 1/20 0.38
MMP2 P08253 1/20 0.38
MMP8 P22894 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29743086 0.78 BRD4 (0.42) TP53BRD4
SCHEMBL1156104 0.74 MAPT (0.50) ALDH1A1KDM4EMAPTBRD4L3MBTL1
SCHEMBL27250286 0.73 HDAC1 (0.40) ALDH1A1KDM4EMAPTSLC6A3L3MBTL1
SCHEMBL31264670 0.72 RHEB (0.38) ALDH1A1KDM4EMAPK1MAP2K1TDP1
SCHEMBL20506939 0.71 TNF (0.37) ALDH1A1KDM4EMAPTLMNAHTT
SCHEMBL23709588 0.71 RHEB (0.67) LIPGALDH1A1KDM4EHPGDSCN4A
SCHEMBL6290676 0.70 ALDH1A1 (0.61) ALDH1A1MAPTMAPK1MAP2K1TDP1
SCHEMBL16793159 0.69 L3MBTL1 (0.46) ALDH1A1KDM4EHPGDMAPTTDP1
SCHEMBL1156102 0.69
SCHEMBL6290609 0.68 ALDH1A1 (0.58) ALDH1A1MAPTMAPK1MAP2K1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732456-B2 Pyridone derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-06-08 US disclosed
US-20070208046-A1 Pyridone derivative MSD K.K. (JP) 2007-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208046-A1 Pyridone derivative CHRM1, XDH, MTR LIPG 4860/4885ALDH1A1 1714/4885KDM4E 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.